Combination of Biological Agents in Moderate to Severe Pediatric Inflammatory Bowel Disease: A Case Series and Review of the Literature

BACKGROUND: Treatment with biological agents such as anti-tumor necrosis factors (TNFs) has become standard of care in moderate to severe pediatric inflammatory bowel disease (IBD). However, a significant proportion of patients experience loss of response to anti-TNFs, need treatment escalation, or...

Descripción completa

Detalles Bibliográficos
Autores principales: Olbjørn, Christine, Rove, Jon Bergreen, Jahnsen, Jørgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383034/
https://www.ncbi.nlm.nih.gov/pubmed/32378002
http://dx.doi.org/10.1007/s40272-020-00396-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383034/
https://www.ncbi.nlm.nih.gov/pubmed/32378002
http://dx.doi.org/10.1007/s40272-020-00396-1

Ejemplares similares